OpenHDI · Open Health Data Impact

The University of Manchester: European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates.

Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.

Organisation
The University of Manchester
Source reference
DARS-NIC-148264-XXC29-v0.0
Jurisdiction
England
Licence
Open Government Licence v3.0, subject to NHS England terms and exclusions

European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates. Title appearing in all publications: the European Male Ageing study (EMAS). Identify and quantify any disparities in the prevalence, incidence, nature and severity of symptoms and disabilities of ageing in the general male population from different regions of the EU. Explain regional differences in the health status of ageing men on the basis of the decline in endocrine (hormonal) functions. Elucidate the relationships between cl

Register reference
DARS-NIC-148264-XXC29-v0.0
Agreement period
not published to no end date published
For commercial purposes (as marked in the register)
Not stated
Release files listed by NHS England
6

Data approved

  • MRIS - Cause of Death Report
  • MRIS - Cohort Event Notification Report

Objective, as published

European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates. Title appearing in all publications: the European Male Ageing study (EMAS). Identify and quantify any disparities in the prevalence, incidence, nature and severity of symptoms and disabilities of ageing in the general male population from different regions of the EU. Explain regional differences in the health status of ageing men on the basis of the decline in endocrine (hormonal) functions. Elucidate the relationships between clinical features associated with ageing and the attendant hormonal changes. Characterise threshold hormone levels for symptomatic and asymptomatic deficiency states in elderly men (i.e. identify the low hormone levels at which older men may become unwell or impaired). Identify potentially modifiable region-specific and/or race/ethnicity-specific risk factors for the evolution and progression of symptoms, disabilities, changes in body composition and hormonal decline associated with ageing in the EU. Inform European policy-makers and industry and formulate recommendations for screening, prevention, diagnosis and treatment of individual functional disabilities or an ageing-related clinical syndrome in men if it is found to exist.

Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/23167/Data-Release-Register-September---November-2016/xls/Data_Release_Register__September_-_November_2016.xlsx. Captured 2026-10-30.

Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.